We are live on ! Find out more
SGMO

SANGAMO THERAPEUTICS INC
SGMO

Delisted

SGMO was delisted on the 4th of May, 2026.

Back to rankings

184 hedge funds and large institutions have $744M invested in SANGAMO THERAPEUTICS INC in 2019 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 59 increasing their positions, 41 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

44% more repeat investments, than reductions

Existing positions increased: 59 | Existing positions reduced: 41

23% more call options, than puts

Call options by funds: $14.9M | Put options by funds: $12.1M

1.73% more ownership

Funds ownership: 69.25% → 70.98% (+1.7%)

1% less funds holding

Funds holding: 185 → 184 (-1)

4% less first-time investments, than exits

New positions opened: 24 | Existing positions closed: 25

14% less capital invested

Capital invested by funds: $860M → $744M (-$116M)

Holders
184
Holders Change
-1
Holders Change %
-0.54%
% of All Funds
4.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
24
Increased
59
Reduced
41
Closed
25
Calls
$14.9M
Puts
$12.1M
Net Calls
+$2.81M
Net Calls Change
-$7.64M

Top Buyers

Rank Fund Capital Flow
1
MWNA
Marshall Wace North America
New York
+$11.6M
2
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance)
Ontario, Canada
+$6.07M
3
Jennison Associates
Jennison Associates
New York
+$5.78M
4
Morgan Stanley
Morgan Stanley
New York
+$4.21M
5
WA
Wasatch Advisors
Utah
+$3.36M

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$6.28M
2
Deutsche Bank
Deutsche Bank
Germany
-$6.22M
3
State Street
State Street
Massachusetts
-$3.69M
4
SFM
Sphera Funds Management
Israel
-$3.03M
5
Fidelity Investments
Fidelity Investments
Massachusetts
-$2.65M
Name Holding Trade Value Shares
Change 		Change in
Stake
Wellington Management Group
1
Wellington Management Group
Massachusetts
$98.5M -$1.76M -156,903 -1%
BlackRock
2
BlackRock
New York
$86.8M +$1.84M +164,223 +2%
Vanguard Group
3
Vanguard Group
Pennsylvania
$75.4M +$291K +25,945 +0.3%
WA
4
Wasatch Advisors
Utah
$62.4M +$3.36M +299,615 +5%
State Street
5
State Street
Massachusetts
$45.4M -$3.69M -328,832 -6%
BG
6
Bellevue Group
Switzerland
$33M – – –
CS
7
Credit Suisse
Switzerland
$22.3M +$1.17M +104,529 +4%
Fidelity Investments
8
Fidelity Investments
Massachusetts
$22.1M -$2.65M -235,900 -9%
Citadel Advisors
9
Citadel Advisors
Florida
$19.8M +$3.17M +282,533 +15%
Dimensional Fund Advisors
10
Dimensional Fund Advisors
Texas
$19.2M +$1.86M +165,780 +8%
Geode Capital Management
11
Geode Capital Management
Massachusetts
$13.9M +$525K +46,818 +3%
Northern Trust
12
Northern Trust
Illinois
$13.7M +$1.58M +141,263 +10%
CC
13
Casdin Capital
New York
$13.2M -$841K -75,000 -5%
Goldman Sachs
14
Goldman Sachs
New York
$11.4M +$791K +70,518 +6%
MWNA
15
Marshall Wace North America
New York
$9.34M +$11.6M +1,031,814 New
BBA
16
Baker Bros. Advisors
New York
$9.05M – – –
AC
17
Alexandria Capital
Virginia
$8.18M -$106K -9,469 -1%
Deutsche Bank
18
Deutsche Bank
Germany
$8.17M -$6.22M -554,190 -38%
UBS AM
19
UBS AM
Illinois
$7.59M +$442K +39,399 +5%
Wells Fargo
20
Wells Fargo
California
$7.58M +$187K +16,710 +2%
Morgan Stanley
21
Morgan Stanley
New York
$7.22M +$4.21M +374,935 +89%
N
22
Nuveen
North Carolina
$6.7M -$563K -50,171 -6%
RPAM
23
Rhenman & Partners Asset Management
Sweden
$6.65M -$664K -59,146 -7%
Charles Schwab
24
Charles Schwab
California
$6.31M +$230K +20,536 +3%
PAMU
25
Pictet Asset Management (UK)
United Kingdom
$5.75M – – –
1
2 3 4 5

SGMO Hedge Fund Activity: Q3 2019 in Review

184 of the 4,561 institutional investors tracked by Wall St. Rank reported a position in SANGAMO THERAPEUTICS INC (SGMO) for Q3 2019, worth a combined $744M — down 14% from $860M a quarter earlier.

Sellers outnumbered buyers: 25 funds closed out of SGMO and 24 opened new positions — a net loss of 1 holder — while 41 trimmed existing stakes and 59 added.

The largest buyer was Marshall Wace North America, opening a new position worth an estimated $11.6M. The largest seller was Renaissance Technologies, cutting an estimated $6.28M.

  • 184 institutional investors held SANGAMO THERAPEUTICS INC (SGMO) as of Q3 2019, down from 185 in Q2 2019.
  • Funds reported $744M of SANGAMO THERAPEUTICS INC stock for Q3 2019, down 14% quarter-over-quarter.
  • 24 funds opened new SANGAMO THERAPEUTICS INC positions in Q3 2019 and 25 closed out, a net change of -1 holder.
  • The largest SANGAMO THERAPEUTICS INC buyer in Q3 2019 was Marshall Wace North America, an estimated $11.6M added.
  • The largest SANGAMO THERAPEUTICS INC seller in Q3 2019 was Renaissance Technologies, an estimated $6.28M sold.

Based on aggregated 13F filings for Q3 2019.